[144] Ormat Technologies, Inc. SEC Filing
Ormat Technologies, Inc. (ORA) filed a Form 144 indicating a proposed insider sale of common stock.
The filing covers 564 shares valued at $47,187 (based on the market price as of the filing) to be executed through Morgan Stanley Smith Barney LLC on or after 18 June 2025 on the NYSE. The shares represent approximately 0.0009 % of the company’s 60,662,626 shares outstanding, signalling an immaterial percentage of equity.
The seller acquired the shares on 18 June 2025 via Stock Appreciation Rights and will pay cash upon exercise. The same individual—identified in the past-3-month sales table as Jessica Woelfel—has already sold 170 shares on 25 March 2025, generating gross proceeds of $12,165.20.
No earnings data, strategic transactions or material corporate developments are disclosed; the form is strictly a notice of intent to sell securities. Given the negligible size relative to the public float, the transaction is unlikely to affect liquidity, control, or valuation for current investors.
- None.
- None.
Insights
TL;DR: Small Form 144—564 ORA shares (~$47k); negligible 0.0009 % float—market impact neutral.
This Form 144 simply notifies a prospective insider sale of 564 Ormat Technologies shares. With 60.7 million shares outstanding, the trade is immaterial, unlikely to pressure share price or signal strategic intent. The prior 170-share sale also appears routine. No red flags such as executive exodus, litigation, or guidance changes accompany the filing. Overall, I classify the disclosure as housekeeping rather than a catalyst.
TL;DR: Routine insider trade filing, complies with Rule 144; no governance concerns detected.
Rule 144 requires insiders to pre-notify sales exceeding de minimis thresholds. The filer provides broker details, acquisition method (SARs), and attests to non-possession of undisclosed MNPI, indicating procedural compliance. The absence of 10b5-1 plan adoption date suggests discretionary timing but the share count is minimal, limiting any governance implications. I view the event as standard compliance with no adverse signals.